Skip to main content
Equibles
ELUT logo

ELUT · Elutia Inc. · Webcasts, Transcripts & Audio

Track ELUT — free

Use ELUT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELUT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.82 +0.04 (+5.51%) At close · Oct 5
Rebalance outlook locked
Market Cap
$36.39M
Shares
44.29M
Volume · Oct 5 256.24K Avg daily vol (3M) 174.88K

Elutia Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Elutia Inc. (ELUT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲3.9% $12.64M −$9.40M '22 Q2 22-08-11 ▼49.1% $5.85M −$9.91M '22 Q3 22-11-17 ▼44.4% $6.39M −$7.97M '23 Q1 23-05-10 ▼49.7% $6.35M −$10.62M '23 Q2 23-08-14 ▲4.8% $6.13M −$9.75M '23 Q3 23-11-13 · $5.88M −$9.31M '23 Q4 24-03-07 ▲4.7% $6.69M −$17.99M '24 Q1 24-05-09 ▼0.9% $6.29M −$28.18M '24 Q2 24-08-07 ▼40.2% $3.66M $1.29M '24 Q3 24-11-14 ▼137.1% $ −$9.06M '24 Q4 25-02-03 ▼55.9% $2.95M −$3.93M '25 Q1 25-05-08 ▼56.3% $2.75M −$9.61M '25 Q2 25-08-14 ▼9.3% $3.32M −$3.87M '25 Q3 25-11-06 · $3.27M $70.79M '25 Q4 26-03-11 ▲5.5% $3.11M −$7.47M '26 Q1 26-05-14 LATEST ▼11.6% $2.43M −$7.65M '26 Q2 26-08-13
Earnings call
FY26 · Q2
2026-08-13
Elutia Inc. (ELUT) Q2 2026 Earnings Call Transcript
Confident tone Regulatory pathway NXT 41X surgeon demand survey Plastic and reconstructive market opportunity
Revenue
$2.43M
▼ 11.6% YoY
Diluted EPS
$-0.17
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
Elutia Inc. (ELUT) Q1 2026 Earnings Call Transcript
Confident tone NXT 41/NXT 41X regulatory progress Post-operative infection and complications Automated manufacturing platform
Revenue
$3.11M
▲ 5.5% YoY
Diluted EPS
$-0.17
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Elutia Inc. (ELUT) Q4 2025 Earnings Call Transcript
Confident tone 41X Breast Reconstruction Drug-Eluting Platform Regulatory Pathway (NXT 41 then 41X) Clinical Efficacy and Data (Plate and Powder)
Revenue
$3.27M*
Gross margin
58.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript
Confident tone SimpliDerm commercialization Breast reconstruction opportunity (NXT-41x) Boston Scientific sale / transaction validation
Revenue
$3.32M
▼ 9.3% YoY
Diluted EPS
$-0.19
Gross margin
55.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Elutia Inc. (ELUT) Q2 2025 Earnings Call Transcript
Confident tone EluPro commercial launch and growth Breast reconstruction pipeline / NXT-41 Business development / strategic transactions
Revenue
$2.75M
▼ 56.3% YoY
Diluted EPS
$-0.26
Gross margin
52.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Elutia Inc. (ELUT) Q1 2025 Earnings Call Transcript
Confident tone EluPro launch performance Boston Scientific partnership Manufacturing capacity
Revenue
$2.95M
▼ 55.9% YoY
Diluted EPS
$-0.21
Gross margin
46.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Elutia Inc. (ELUT) Q4 2024 Earnings Call Transcript
Confident tone EluPro product launch Market opportunity vs. Medtronic TYRX Boston Scientific distribution partnership
Revenue
$*
▼ 137.1% YoY
Gross margin
32.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript
Confident tone EluPro Product Launch SimpliDerm Performance Financial Performance
Revenue
$3.66M
▼ 40.2% YoY
Diluted EPS
$-0.33
Gross margin
48.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Elutia Inc. (ELUT) Q2 2024 Earnings Call
Revenue
$6.29M
▼ 0.9% YoY
Diluted EPS
$-1.13
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Elutia Inc. (ELUT) Q1 2024 Earnings Call Transcript
Confident tone CanGarooRM FDA clearance and launch readiness Market opportunity vs. TYRX/Medtronic SimpliDerm commercial momentum
Revenue
$6.69M
▲ 4.7% YoY
Diluted EPS
$-0.75
Gross margin
42.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
Elutia Inc. (ELUT) Q4 2023 Earnings Call Transcript
Confident tone CanGarooRM FDA clearance and launch CanGaroo legacy product SimpliDerm growth
Revenue
$5.88M*
Gross margin
36.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Elutia Inc. (ELUT) Q3 2023 Earnings Call Transcript
Revenue
$6.13M
▲ 4.8% YoY
Diluted EPS
$-0.57
Gross margin
46.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Elutia Inc. (ELUT) Q2 2023 Earnings Call Transcript
Revenue
$6.35M
▼ 49.7% YoY
Diluted EPS
$-0.65
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Elutia Inc. (ELUT) Q1 2023 Earnings Call Transcript
Revenue
$6.39M
▼ 44.4% YoY
Diluted EPS
$-0.49
Gross margin
52.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-17
Elutia Inc. (ELUT) Q3 2022 Earnings Call
Revenue
$5.85M
▼ 49.1% YoY
Diluted EPS
$-0.73
Gross margin
50.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Elutia Inc. (ELUT) Q2 2022 Earnings Call
Revenue
$12.64M
▲ 3.9% YoY
Diluted EPS
$-0.69
Gross margin
38.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Elutia Inc. (ELUT) Q1 2022 Earnings Call
Revenue
$11.49M
▼ 10.8% YoY
Diluted EPS
$-0.60
Gross margin
37.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-10-25
Elutia Inc. (ELUT) Q3 2021 Earnings Call
Revenue
$11.48M
▼ 2.5% YoY
Diluted EPS
$-0.81
Gross margin
32.1%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Elutia Inc. (ELUT) Q2 2021 Earnings Call
Revenue
$12.16M
▲ 41.7% YoY
Diluted EPS
$-0.23
Gross margin
46.2%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Elutia Inc. (ELUT) Q1 2021 Earnings Call
Revenue
$12.88M
▲ 30.6% YoY
Diluted EPS
$-0.50
Gross margin
49.1%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Elutia Inc. (ELUT) Q4 2020 Earnings Call
Revenue
$12.47M*
Gross margin
48.3%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-19
Elutia Inc. (ELUT) Q3 2020 Earnings Call
Revenue
$11.77M
▲ 5.7% YoY
Diluted EPS
$-15.79
Gross margin
47.1%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 webcasts
Key facts CIK 1708527 CUSIP 05479K106 13F (30d) 1 filings 1 filers Visit website Investor relations